Clinical Trials Logo

PULSE WAVE VELOCITY clinical trials

View clinical trials related to PULSE WAVE VELOCITY.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06224517 Recruiting - Ischemic Stroke Clinical Trials

Pulse Wave Velocity and in Subacute Stroke Patients Following Rehabilitation

Start date: February 1, 2024
Phase:
Study type: Observational

Currently, the literature regarding the relationship between Pulse Wave Velocity (PWV) and functional recovery, particularly of upper limb function, in patients with subacute stroke is still limited. Therefore, the aim of the study is to evaluate the changes in baPWV after four weeks of intensive rehabilitation therapy, and the correlation between these changes and functional recovery.

NCT ID: NCT03262753 Recruiting - Arterial Stiffness Clinical Trials

Long-term Outcomes and Vascular Evaluation After Coarctation of the Aorta Treatment

LOVE-COARCT
Start date: June 1, 2013
Phase: N/A
Study type: Observational

Background: Coarctation of the aorta (CoA) can be treated using surgery, balloon angioplasty or stent implantation. Although short-term results are excellent with all three treatment modalities, long term cardiovascular (CV) morbidity and mortality remain high, likely due to persistently abnormal vascular function. The effects of treatment modality on long term vascular function remain uncharacterized. The goal of this study is to assess vascular function in this patient population for comparison among the treatment modalities. Methods: Vascular function in large and small arteries will be prospectively assessed fusing multiple non-invasive modalities, and the results will be compared among the three groups of CoA patients previously treated using surgery, balloon angioplasty or stent implantation after frequency matching for confounding variables. A comprehensive vascular function assessment protocol was created to be used in 7 centers. The primary outcome is arterial stiffness measured by arterial tonometry. Inclusion and exclusion criteria were carefully established after consideration of several potential confounders. Sample size was calculated for the primary outcome variable. Conclusions: Treatment modalities for CoA may have distinct impact on large and small arterial vascular function. The results of this study will help identify the treatment modality that is associated with the most optimal level of vascular function, which, in the long term may reduce CV risk.